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Aaron M Hosios1 and Matthew G Vander Heiden1,2*Macromolecule biosynthesis is required to duplicate cell
components and support proliferation. Studies examin-
ing the nutrients used by cancer cells have focused on
the contribution of glucose and glutamine carbon for
biosynthesis, but the importance of other metabolic fuels
is becoming apparent. Labeling of two-carbon units in
newly synthesized lipids has been used to infer the nutri-
ents that contribute to the acetyl-CoA pools in cells.
Glucose- and glutamine-derived carbon are known to
contribute extensively to de novo lipid biosynthesis, and
in this issue Kamphorst et al. find that extracellular acet-
ate can also contribute substantially to this process [1].
In normoxia, glucose and glutamine together account
for the majority of lipogenic acetyl-CoA, but this
fraction falls substantially in hypoxia [2,3]. In hypoxia,
flux from glucose to citrate as a source of acetyl-coA
decreases, and cells utilize alternative carbon sources to
generate this metabolite. Glutamine can provide some of
this carbon through reductive carboxylation of glutamine-
derived α-ketoglutarate to citrate [2,4], but a substantial
amount of acetyl-CoA is labeled by neither glucose nor
glutamine tracing. Breakdown of lipids scavenged from the
environment is one alternate source of acetyl-CoA, but
mammalian serum also contains acetate, and the authors
found that exogenous acetate could be incorporated into
acetyl-CoA and become available for lipid biosynthesis.
Surprisingly, for some cell lines in hypoxia, acetate may be a
major contributor to acetyl-CoA.
Acetate is transported into cells by members of the
monocarboxylate transporter family [5] where acetyl-CoA
synthetases (ACSS) catalyze conversion to acetyl-CoA.
Mammalian cells express mitochondrial and cytosolic
forms of ACSS, and the authors cite emerging data from
other groups that this enzyme can be important for
growth of some tumors. Kamphorst et al. observe that
acetate labels acetyl-CoA in hypoxic cells only, and it is
interesting to consider whether this is due to increased
acetate uptake or increased ACSS activity in low oxygen.* Correspondence: mvh@mit.edu
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article, unless otherwise stated.Alternatively, it is possible that reduced synthesis of
acetyl-CoA from glucose permits other sources of two-
carbon units such as acetate to equilibrate with acetyl-
CoA and have a higher fractional contribution to pools
in cells.
For the labeling experiments acetate was provided to
cells exogenously, but Kamphorst et al.’s findings raise
the question of what sources of acetate exist in vivo.
Acetate is present in human and murine blood at con-
centrations ranging from 50–200 μM [6-9] but has been
estimated to be as high as 500–600 μM by some [10,11].
There can be substantial variability of acetate concentra-
tions across species with higher levels observed in cows
relative to human, perhaps explaining why Kamphorst
et al. measure high levels of acetate in bovine serum
[12]. Acetate in plasma is supplied by both exogenous
and endogenous sources. Exogenous acetate delivered to
tumors via the blood may derive from the diet, with a
substantial portion generated by gut microbiome metab-
olism of intestinal contents [13]. Fasting induces the
liver to generate ketones for metabolism by other tissues.
Starvation itself reduces circulating acetate [14], presum-
ably because dietary sources of acetate are lacking; how-
ever when ketones are consumed by cells they generate
acetyl-CoA. Finally, exogenous acetate can be generated
from the oxidation of ethanol. In some individuals, this
can be a major source of acetate, and chronic drinkers
may have circulating acetate concentrations as high as
the millimolar range [10,15]. In the hours following etha-
nol consumption, blood acetate has also been observed to
reach similar levels [16], but it has also been suggested
that ethanol-derived acetate is primarily trapped in the
liver by high ACSS activity [13].
Acetate may also be generated in a cell’s microenviron-
ment. Protein deacetylases and acetyl-CoA hydrolase
both generate acetate via hydrolysis reactions [14], sug-
gesting that release of acetyl groups from endogenous
sources may contribute to the acetate pool, and raising
the possibility that some cells could produce acetate
used by neighboring cells. Kamphorst et al. find that
acetate’s contribution to lipid biosynthesis is greatest
when cells are hypoxic, suggesting that substantial acetateioMed Central Ltd. This is an Open Access article distributed under the terms of
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the blood are not available. This argues that acetate pro-
duced locally in the microenvironment would be the
major source available in this context. Future work should
clarify the use of circulating acetate by tumors, or whether
the contribution of locally generated acetate predominates.
It will also determine the importance of acetate use for
proliferation and tumor progression, and elucidate why the
use of acetate might be advantageous to cancer cells.
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